Lysosomal Storage Diseases Therapeutics Market to reach US$ 15,792.6 Million globally by 2027 – Coherent Market Insights SEATTLE, May 25, 2020 (GLOBE NEWSWIRE) -- Lysosomal Storage Diseases (LSDs) are inherited disorders caused due to lack of specific enzymes that break down certain lipids or carbohydrates in the body...

Global Metabolism Drugs Market to Surpass US$ 9.9 Billion by 2026 – Coherent Market Insights Seattle, July 16, 2018 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global metabolism drugs market was valued at US$ 5,765.3 million in 2017 and is projected to exhibit a CAGR of...